Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIMDW
Ainos
$0.05
+25.0%
$0.07
$0.04
$0.64
N/AN/A3,881 shs10,692 shs
BBLGW
Bone Biologics
$35.02
$21.63
$0.43
$46.80
N/AN/A2,816 shsN/A
COCHW
Envoy Medical
$0.07
$0.14
$0.01
$0.32
N/AN/A91,572 shs15,821 shs
DHAIW
DIH Holding US
$0.05
$0.03
$0.01
$0.06
N/AN/A142,215 shsN/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIMDW
Ainos
0.00%-11.03%-38.80%-0.40%-81.80%
BBLGW
Bone Biologics
0.00%+45.86%+40.02%+600.40%+3,791.11%
COCHW
Envoy Medical
0.00%-7.41%-53.33%+426.08%+6,999,900.00%
DHAIW
DIH Holding US
+393.07%+17.73%+24.50%+4,979,900.00%+4,979,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIMDW
Ainos
N/AN/AN/AN/AN/AN/AN/AN/A
BBLGW
Bone Biologics
N/AN/AN/AN/AN/AN/AN/AN/A
COCHW
Envoy Medical
N/AN/AN/AN/AN/AN/AN/AN/A
DHAIW
DIH Holding US
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIMDW
Ainos
N/AN/AN/AN/A
BBLGW
Bone Biologics
N/AN/AN/AN/A
COCHW
Envoy Medical
N/AN/AN/AN/A
DHAIW
DIH Holding US
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIMDW
Ainos
$93.68KN/AN/AN/AN/AN/A
BBLGW
Bone Biologics
N/AN/AN/AN/AN/AN/A
COCHW
Envoy Medical
$316KN/AN/AN/AN/AN/A
DHAIW
DIH Holding US
$55.00MN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIMDW
Ainos
N/AN/A0.00N/AN/AN/AN/AN/A
BBLGW
Bone Biologics
N/AN/A0.00N/AN/AN/AN/AN/A
COCHW
Envoy Medical
N/AN/A0.00N/AN/AN/AN/AN/A
DHAIW
DIH Holding US
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIMDW
Ainos
N/AN/AN/AN/AN/A
BBLGW
Bone Biologics
N/AN/AN/AN/AN/A
COCHW
Envoy Medical
N/AN/AN/AN/AN/A
DHAIW
DIH Holding US
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AIMDW
Ainos
N/A
BBLGW
Bone Biologics
N/A
COCHW
Envoy Medical
N/A
DHAIW
DIH Holding US
N/A

Insider Ownership

CompanyInsider Ownership
AIMDW
Ainos
N/A
BBLGW
Bone Biologics
N/A
COCHW
Envoy Medical
N/A
DHAIW
DIH Holding US
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AIMDW
Ainos
46N/AN/ANot Optionable
BBLGW
Bone Biologics
2N/AN/ANot Optionable
COCHW
Envoy Medical
34N/AN/ANot Optionable
DHAIW
DIH Holding US
N/AN/AN/AN/A

DHAIW, AIMDW, BBLGW, and COCHW Headlines

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Ainos

NASDAQ:AIMDW
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Bone Biologics

NASDAQ:BBLGW
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Envoy Medical

NASDAQ:COCHW
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

DIH Holding US

NASDAQ:DHAIW
DIH Holding US, Inc. operates as a robotics and virtual reality technology provider in the rehabilitation and human performance industry. The company is based in Norwell, Massachusetts.